🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Deventer
Clinical trial register · Netherlands

Clinical Trials in Deventer, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3203 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
3203
Studies in scope
all four open statuses
1832
Recruiting now
open to new participants
608
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1240 Rotterdam 867 Groningen 601 Nijmegen 559 Utrecht 541
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The Netherlands Cancer Institute4 UMC Utrecht4 Merck Sharp & Dohme LLC3 Population Health Research Institute3 University Medical Center Groningen3
Site location
Amsterdam1240 Rotterdam867 Groningen601 Nijmegen559 Utrecht541
All 161 locations
Target enrolment
to

Trials with a site in Deventer

54 of 3203 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
NCT07361510Non-Small Cell Lung Cancer (NSCLC)
DrugsPumitamig·Pembrolizumab
Bristol-Myers Squibb
Phase 3
750
Nijmegen, Breda, 's-Hertogenbosch, Amersfoort, Deventer, Tilburg
2026-03-12
Recruiting
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
NCT07252739Malignant Neoplasm
DrugsMK-1084·Sacituzumab tirumotecan·Cetuximab·Keytruda
Merck Sharp & Dohme LLC
Phase 2
140
Deventer, Leiden
2025-12-19
Active, closed
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
NCT07219602Lipidemia, Type 2 Diabetes (T2DM), Metabolic Syndrome (MetS)
DrugsEzetimibe FDC·Obicetrapib
NewAmsterdam Pharma
Phase 3
300
Hoogeveen, Arnhem, Alkmaar, Deventer, Zwijndrecht
2025-12-11
Recruiting
Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs
NCT07309848Blood Transfusion, Hip Fracture Surgeries, Geriatric, Bleeding Complications
St. Antonius Hospital
Observational
374
Almelo, Amsterdam, Arnhem, Deventer, Groningen, Utrecht
2025-11-01
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
NCT07267949Atrial Fibrillation (AF)
Acesion Pharma
Phase 2
200
Arnhem, Deventer, Groningen, Haarlem, Leeuwarden, Maastricht, The Hague, Tiel
2025-10-22
Recruiting
The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients
NCT07173504Critical Illness
Gelderse Vallei Hospital
Not applicable
124
Ede, Deventer, Enschede, Groningen, The Hague
2025-09-30
Recruiting
Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism
NCT06924008Autism Spectrum Disorder (ASD), Relative (Related Person), Care Giver
UMC Utrecht
Observational
18
Deventer
2025-07-07
Recruiting
HAKA: Routine Follow-Up at 1 Year After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?
NCT06971757Hip Arthroplasty, Total, Knee Arthroplasty, Total
JointResearch
Not applicable
1,000
Amsterdam, Breda, Deventer, Goes, Groningen, Hilversum, Nijmegen, Terneuzen
2025-07-01
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Amsterdam, Arnhem, Breda, Delft, Deventer, Dordrecht, Eindhoven, Emmen
2025-06-25
Recruiting
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT06462963Breast Cancer, Prostate Cancer, NSCLC, Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
302
Deventer, Nijmegen
2025-04-15
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
NCT06841354Triple Negative Breast Neoplasms
DrugsSacituzumab tirumotecan·Nab-paclitaxel·Gemcitabine·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
1,000
Arnhem, Sittard Geleen, Tilburg, Deventer, Rotterdam, Amersfoort, Groningen
2025-03-16
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060Heart Failure
AstraZeneca
Phase 3
11,300
's-Hertogenbosch, Almelo, Amsterdam, Born, Deventer, Ede, Enschede, Haarlem
2025-03-14
Recruiting
Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease
NCT06871514Atherosclerotic Cardiovascular Diseases, Shared-decision Making
dr.Frank L.J. Visseren
Not applicable
1,200
Alkmaar, Amersfoort, Deventer, Ede, Nijmegen, The Hague, Utrecht
2025-02-18
Recruiting
Course of Face-to-face Interactions in Adults With Autism
NCT06925308Autism Spectrum Disorder (ASD), Neurotypical
UMC Utrecht
Not applicable
54
Deventer
2025-02-03
Recruiting
The OPTIMISE Study
NCT05716945Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure
DrugDexamethasone ophthalmic
Maastricht University Medical Center
Phase 4
342
Apeldoorn, Nijmegen, Maastricht, Amsterdam, Deventer, Groningen, Leiden, Utrecht
2024-07-29
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288Heart Failure
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
6,712
's-Hertogenbosch, Arnhem, Breda, Deventer, Eindhoven, Gouda, Leiderdorp, Nieuwegein
2024-06-17
Recruiting
Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)
NCT07001709Prostate Cancer, Pain Cancer
DrugsOxycodone·Abiraterone acetate
Deventer Ziekenhuis
Phase 4
29
Deventer
2024-04-12
Recruiting
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492Stage III Non-small Cell Lung Cancer
Radboud University Medical Center
Not applicable
690
Hilversum, Amsterdam, Apeldoorn & Zutphen, Breda, Deventer, Ede, Eindhoven & Veldhoven, Emmen
2024-03-19
Active, closed
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
NCT06292013Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
DrugLepodisiran
Eli Lilly and Company
Phase 3
17,300
Amersfoort, Amsterdam, Apeldoorn, Beverwijk, Delft, Deventer, Doetinchem, Ede
2024-03-05
Recruiting
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
NCT07260435Prostate Cancer
Nick Beije
Phase 3
400
Alkmaar, Amersfoort, Amsterdam, Assen, Beverwijk, Deventer, Eindhoven, Emmen
2024-02-20
Recruiting
PT-STRESS Study: Predicting Treatment Success and Dealing With Non-response in the Treatment of PTSD
NCT06279598Stress Disorders, Post-Traumatic
University of Groningen
Not applicable
442
Deventer
2024-01-01
Active, closed
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059Ulcerative Colitis
DrugTulisokibart
Merck Sharp & Dohme LLC
Phase 3
1,020
Nijmegen, Tilburg, Uden, Amsterdam, Deventer, Rotterdam, Utrecht
2023-10-25
Recruiting
COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
NCT05301881Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive
The Netherlands Cancer Institute
Phase 2
56
Alkmaar, Amsterdam, Arnhem, Deventer, Goes, Groningen, Utrecht
2023-04-17
Active, closed
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869Atrial Fibrillation
DrugsMilvexian·Apixaban
Janssen Research & Development, LLC
Phase 3
20,284
's-Hertogenbosch, Alkmaar, Almelo, Amersfoort, Amsterdam, Delft, Deventer, Doetinchem
2023-04-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Arnhem, Doetinchem, Nijmegen, 's-Hertogenbosch, Tilburg, Amsterdam, Beverwijk, Deventer
2023-03-09
By invitation
Oral Immunotherapy in Young Children With Food Allergy
NCT05738798Food Allergy
Deventer Ziekenhuis
Not applicable
500
Deventer, Amsterdam, Delft, Groningen
2023-02-01
Recruiting
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
NCT05326620Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic
PROspective Renal Cancer Cohort Foundation
Observational
2,000
Amsterdam, 's-Hertogenbosch, Amersfoort, Apeldoorn, Arnhem, Breda, Deventer, Dordrecht
2023-01-19
Active, closed
MAD Trial: Myopia Atropine Dose
NCT05667454Progressive Myopia
Erasmus Medical Center
Phase 3
550
Almere Stad, Amsterdam, Delft, Deventer, Dordrecht, Ede, Goes, Heerenveen
2022-12-19
Active, closed
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
NCT05581303Atherosclerotic Cardiovascular Disease
DrugOlpasiran
Amgen
Phase 3
7,297
Amersfoort, Amsterdam, Apeldoorn, Arnhem, Bergen op Zoom, Breda, Delft, Deventer
2022-12-14
Active, closed
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
NCT05514054Breast Neoplasms
DrugsImlunestrant·Tamoxifen·Exemestane·Anastrozole
Eli Lilly and Company
Phase 3
8,000
Assen, Breda, Delft, Deventer, Dordrecht, Hengelo, Hoofddorp, Maastricht
2022-10-04
Recruiting
Perpetual Observational Study - Ventilator Associated Pneumonia
NCT05719259Ventilator Associated Pneumonia
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Observational
20,000
Deventer, Utrecht
2022-08-03
Recruiting
abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
NCT05431101Carpal Tunnel Syndrome, Wound Infection, Suture, Complication
Gelre Hospitals
Not applicable
2,604
Apeldoorn, Deventer
2022-05-01
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Deventer, Amsterdam
2021-11-22
Active, closed
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
NCT04927780Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
DrugsLeucovorin Calcium·Fluorouracil·Irinotecan·Oxaliplatin
Erasmus Medical Center
Phase 3
378
's-Hertogenbosch, Amersfoort, Amsterdam, Breda, Deventer, Eindhoven, Enschede, Groningen
2021-09-07
By invitation
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
NCT04957719Acute Myocardial Infarction
Viatris Innovation GmbH
Phase 3
25,000
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Apeldoorn, Arnhem, Breda, Deventer
2021-08-14
Active, closed
Leiden Thrombosis Recurrence Risk Prevention
NCT06087952Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis
Leiden University Medical Center
Not applicable
608
Leiden, Amsterdam, Assen, Beverwijk, Breda, Deventer, Drachten, Ede
2021-06-18
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
NCT04774159Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation
DrugColchicine
Population Health Research Institute
Phase 3
6,150
Deventer, Doetinchem, Groningen, Utrecht
2021-05-06
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Deventer, Geldrop, Maastricht, Zwolle
2021-04-24
Recruiting
Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
NCT05772923Organ Preservation, Rectal Cancer, Quality of Life, Locally Advanced Rectal Carcinoma
The Netherlands Cancer Institute
Not applicable
168
Nijmegen, Eindhoven, Amsterdam, Deventer, Zwolle, Leeuwarden, Capelle aan den IJssel
2021-04-16
Recruiting
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
NCT04642027Prostate Cancer, Cancer Recurrence
University Medical Center Groningen
Phase 3
538
Arnhem, Nijmegen, Maastricht, Eindhoven, Tilburg, Amsterdam, Deventer, Leeuwarden
2020-09-01
Recruiting
Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA
NCT04183426Abdominal Aortic Aneurysm, Cardiovascular Events
Rijnstate Hospital
Observational
194
Nijmegen, Apeldoorn, Deventer, Ede, Enschede, Veldhoven
2020-06-12
Active, closed
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
NCT04302454Prostate Cancer
DrugsEligard·Leuprorelin
University Medical Center Groningen
Phase 3
280
Arnhem, Nijmegen, Maastricht, Eindhoven, Amsterdam, Deventer, Zwolle, Leeuwarden
2020-03-19
Active, closed
Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
NCT03517137Advanced Hodgkin Lymphoma
DrugsVinblastine·Brentuximab Vedotin·Dacarbazine·Adriamycin
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
150
Amsterdam, Deventer, Groningen, Leeuwarden, Leidschendam, Nijmegen, Rotterdam
2019-08-01
Active, closed
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
NCT03283384Breast Neoplasms
DrugsRibociclib·Letrozole
Borstkanker Onderzoek Groep
Phase 2
100
's-Hertogenbosch, Almelo, Amstelveen, Amsterdam, Apeldoorn, Breda, Delft, Deventer
2019-06-15
Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393Stroke, Atrial Fibrillation
DrugsNon-Vitamin K Anticoagulant·NOAC·Dabigatran·Edoxaban
Population Health Research Institute
Phase 4
2,270
's-Hertogenbosch, Alkmaar, Almelo, Amstelveen, Arnhem, Breda, Deventer, Ede
2019-06-14
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT04075305Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer
UMC Utrecht
Observational
8,000
Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
2019-02-01
Active, closed
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
NCT03574571Prostate Cancer
DrugsXofigo·Docetaxel
Memorial Sloan Kettering Cancer Center
Phase 3
732
Amsterdam, Alkmaar, Almelo, Breda, Deventer, Hilversum, Nijmegen, Rotterdam
2018-06-19
Active, closed
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
NCT02284308NSCLC
Maastricht Radiation Oncology
Observational
180
Almelo, Apeldoorn, Arnhem, Deventer, Ede, Eindhoven, Enschede, Gorinchem
2016-07
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Community-acquired Pneumonia, Influenza, COVID-19
DrugsConvalescent plasma·Repagermanium·Ivermectin·Amoxicillin-clavulanate
UMC Utrecht
Phase 3
20,000
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Deventer, Ede, Eindhoven
2016-04-11
Active, closed
A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients
NCT02301286Colon Cancer, Adjuvant Therapy
DrugsAcetylsalicylic acid·Aspirin
Leiden University
Phase 3
770
Almelo, Amersfoort, Assen, Breda, Capelle aan den IJssel, Delft, Deventer, Doetinchem
2015-01
Active, closed
Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2
NCT01996267Breast Cancer, HER2 Positive
DrugsFEC→T·Pertuzumab
The Netherlands Cancer Institute
Phase 3
437
's-Hertogenbosch, Alkmaar, Almelo, Amsterdam, Beverwijk, Breda, Delft, Deventer
2013-12
Active, closed
Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial
NCT01558921Rectal Cancer
University Medical Center Groningen
Phase 3
920
Groningen, Alkmaar, Amsterdam, Assen, Breda, Delft, Deventer, Eindhoven
2011-06-21
Active, closed
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
NCT01057069Breast Cancer
DrugsDoxorubicin/cyclophosphamide·Carboplatin and Paclitaxel·Paclitaxel·Carboplatin
The Netherlands Cancer Institute
Phase 2/3
310
Alkmaar, Amsterdam, Delft, Deventer, Dordrecht, Ede, Haarlem, Heerlen
2010-01
Active, closed
Psoriasis Longitudinal Assessment and Registry
NCT00508547Psoriasis
Janssen Scientific Affairs, LLC
Observational
20,167
Alkmaar, Amsterdam-Zuidoost, Breda, Deventer, Helmond, Nijmegen
2007-06-21
Rows per page Showing 1–54 of 54
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-netherlands/city/deventer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,203 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 54 of those studies with a site in Deventer.

How many clinical trials are recruiting in Deventer?

32 of the 54 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 0 have not yet opened recruitment, 20 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Deventer), 54 studies
PhaseStudiesRecruitingShare
Phase 324944.4%
Not applicable131124.1%
Observational8614.8%
Phase 2539.3%
Phase 4335.6%
Phase 2/3101.9%

Most active sponsors

Lead sponsors with the most studies (Deventer)
Lead sponsorStudiesRecruiting
The Netherlands Cancer Institute42
UMC Utrecht44
Merck Sharp & Dohme LLC32
Population Health Research Institute33
University Medical Center Groningen31
Amgen21
Deventer Ziekenhuis21
Eli Lilly and Company20
Erasmus Medical Center20
European Organisation for Research and Treatment of Cancer - EORTC21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.